INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 203 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $70,820 | -27.0% | 86,366 | +38.8% | 0.00% | -60.0% |
| Q4 2022 | $97,034 | -23.6% | 62,201 | -15.5% | 0.01% | +25.0% |
| Q3 2022 | $127,000 | -2.3% | 73,597 | +1.7% | 0.00% | 0.0% |
| Q2 2022 | $130,000 | -44.2% | 72,362 | +13.4% | 0.00% | -20.0% |
| Q1 2022 | $233,000 | -29.4% | 63,817 | +0.4% | 0.01% | -28.6% |
| Q4 2021 | $330,000 | -40.9% | 63,584 | -17.2% | 0.01% | -30.0% |
| Q3 2021 | $558,000 | -4.5% | 76,809 | +24.4% | 0.01% | 0.0% |
| Q2 2021 | $584,000 | +4.1% | 61,764 | -3.0% | 0.01% | 0.0% |
| Q1 2021 | $561,000 | -24.4% | 63,673 | -22.7% | 0.01% | -37.5% |
| Q4 2020 | $742,000 | -38.7% | 82,399 | -23.0% | 0.02% | -57.9% |
| Q3 2020 | $1,211,000 | -38.4% | 107,051 | +72.6% | 0.04% | -45.7% |
| Q2 2020 | $1,965,000 | – | 62,020 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 200,000 | $998,000 | 0.36% |
| Green Alpha Advisors, LLC | 72,647 | $363,000 | 0.24% |
| Skaana Management L.P. | 227,851 | $1,137,000 | 0.18% |
| SEVEN EIGHT CAPITAL, LP | 196,351 | $980,000 | 0.18% |
| Defender Capital, LLC. | 103,038 | $514,000 | 0.16% |
| Skaana Management L.P. | 206,300 | $1,029,000 | 0.16% |
| WASATCH ADVISORS LP | 4,926,125 | $24,581,000 | 0.10% |
| Parametrica Management Ltd | 16,183 | $81,000 | 0.08% |
| Cedar Brook Financial Partners, LLC | 54,500 | $272,000 | 0.07% |
| Hennion & Walsh Asset Management, Inc. | 274,703 | $1,371,000 | 0.07% |